Home » Authors » Omar Ford

Omar Ford

Articles

ARTICLES

Simulation: unproven, costly but beginning to gain traction

Oct. 25, 2007

ExThera formed to treat sepsis as latest device/drug matchup

Oct. 22, 2007

Virtual Companies Project used to boost Michigan's economy

Oct. 16, 2007

In $42M buy, QLT has ForSight to address glaucoma patients

Oct. 10, 2007

Apollo in ‘A’ $11.5 million round; Simplex Diabetic garners $50M

Oct. 9, 2007

Panelist: ‘Focus’ essential for medical device start ups

Oct. 8, 2007

Med-tech landscape is sunny, but watch out for ‘storm clouds’

Oct. 5, 2007

Spectranetics launches PATENT trial for SFA instent restenosis

Oct. 3, 2007

Calcification attack, but adjacent tissue safety via Diamondback

Oct. 1, 2007

Product briefs: Digital Health wins PMA for Retasure retinopathy detection

Oct. 1, 2007

View All Articles by Omar Ford

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
BIO 2026: Alternatives to funding orphan drugs
BioWorld
At the BIO International Convention, nonprofit and for-profit companies discussed ways to fund orphan drug development, especially for ultra-rare diseases where...
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...